Protective effect of edaravone for tourniquet-induced ischemia-reperfusion injury on skeletal muscle in murine hindlimb

BMC Musculoskeletal Disorders

Akihiro Sudo²  Atsumasa Uchida¹  Masahiro Hasegawa²  Koji Akeda²  Takeshi Uemura²  Haruhiko Satonaka²  Takahiro Iino²  Masaya Tsujii²  Kazuichiro Hori² 

[1] Mie University, Mie, Japan;Department of Orthopaedic Surgery, Graduate School of Medicine Mie University, 2-174 Edobashi, Tsu city, Mie prefecture 514-8507, Japan

关键词: iNOS;    Edaravone;    Free radical scavenger;    Skeletal muscle;    Ischemia-reperfusion injury;   

Others  :  1133195
DOI  :  10.1186/1471-2474-14-113

 received in 2012-12-12, accepted in 2013-03-21,  发布年份 2013

【 摘 要 】

Background

Studies have shown that ischemia-reperfusion (I/R) produces free radicals leading to lipid peroxidation and damage to skeletal muscle. The purposes of this study were 1) to assess the histological findings of gastrocnemius muscle (GC) and tibialis anterior muscle (TA) in I/R injury model mice, 2) to histologically analyze whether a single pretreatment of edaravone inhibits I/R injury to skeletal muscle in murine models and 3) to evaluate the effect of oxidative stress on these muscles.

Methods

C57BL6 mice were divided in two groups, with one group receiving 3 mg/kg intraperitoneal injections of edaravone (I/R + Ed group) and the other group receiving an identical amount of saline (I/R group) 30 minutes before ischemia. Edaravone (3-methy-1-pheny1-2-pyrazolin-5-one) is a potent and novel synthetic scavenger of free radicals. This drug inhibits both nonenzymatic lipid peroxidation and the lipoxygenase pathway, in addition to having potent antioxidant effects against ischemia reperfusion. The duration of the ischemia was 1.5 hours, with reperfusion at either 24 or 72 hours (3 days). Specimens of gastrocnemius (GC) and anterior tibialis (TA) were removed for histological evaluation and biochemical analysis.

Results

This model of I/R injury was highly reproducible in histologic muscle damage. In the histologic damage score, the mean muscle fibers and inflammatory cell infiltration in the I/R + Ed group were significantly less than the corresponding values of observed in the I/R group. Thus, pretreatment with edaravone was observed to have a protective effect on muscle damage after a period of I/R in mice. In addition, the mean muscle injury score in the I/R + Ed group was also significantly less than the I/R group. In the I/R + Ed group, the mean malondialdehyde (MDA) level was lower than in the I/R group and western-blotting revealed that edaravone pretreatment decreased the level of inducible nitric oxide synthase (iNOS) expression.

Conclusions

Edaravone was found to have a protective effect against I/R injury by directly inhibiting lipid peroxidation of the myocyte by free radicals in skeletal muscles and may also reduce the secondary edema and inflammatory infiltration incidence of oxidative stress on tissue.

【 授权许可】

   
2013 Hori et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 4.

【 参考文献 】

• [1]Carden DL, Granger DN: Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000, 190(3):255-266.
• [2]Chamoun F, Burne M, O'Donnell M, Rabb H: Pathophysiologic role of selectins and their ligands in ischemia reperfusion injury. Frontiers in bioscience: a journal and virtual library 2000, 5:E103-E109.
• [3]de Perrot M, Liu M, Waddell TK, Keshavjee S: Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003, 167(4):490-511.
• [4]Tonon J, Cecchini AL, Brunnquell CR, Bernardes SS, Cecchini R, Guarnier FA: Lung injury-dependent oxidative status and chymotrypsin-like activity of skeletal muscles in hamsters with experimental emphysema. BMC Musculoskelet Disord 2013, 14:39. BioMed Central Full Text
• [5]Crawford RS, Hashmi FF, Jones JE, Albadawi H, McCormack M, Eberlin K, Entabi F, Atkins MD, Conrad MF, Austen WG Jr: A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol 2007, 292(2):H830-H837.
• [6]Walters TJ, Kragh JF, Kauvar DS, Baer DG: The combined influence of hemorrhage and tourniquet application on the recovery of muscle function in rats. J Orthop Trauma 2008, 22(1):47-51.
• [7]Schoen M, Rotter R, Gierer P, Gradl G, Strauss U, Jonas L, Mittlmeier T, Vollmar B: Ischemic preconditioning prevents skeletal muscle tissue injury, but not nerve lesion upon tourniquet-induced ischemia. The Journal of trauma 2007, 63(4):788-797.
• [8]Hsieh CH, Jeng JC, Jeng SF, Wu CJ, Lu TH, Liliang PC, Rau CS, Chen YC, Lin CJ: MicroRNA profiling in ischemic injury of the gracilis muscle in rats. BMC Musculoskelet Disord 2010, 11:123. BioMed Central Full Text
• [9]Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM: The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 1996, 23(3):506-514.
• [10]Shirasugi N, Wakabayashi G, Shimazu M, Oshima A, Shito M, Kawachi S, Karahashi T, Kumamoto Y, Yoshida M, Kitajima M: Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia/reperfusion injury. Transplantation 1997, 64(10):1398-1403.
• [11]Yang Z, Zingarelli B, Szabo C: Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000, 101(9):1019-1026.
• [12]Mallick IH, Yang W, Winslet MC, Seifalian AM: Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004, 49(9):1359-1377.
• [13]McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312(3):159-163.
• [14]Blaisdell FW: The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 2002, 10(6):620-630.
• [15]Blebea J, Cambria RA, DeFouw D, Feinberg RN, Hobson RW, 2nd Duran WN: Iloprost attenuates the increased permeability in skeletal muscle after ischemia and reperfusion. J Vasc Surg 1990, 12(6):657-665. discussion 665–656
• [16]Perry MO, Fantini G: Ischemia: profile of an enemy. Reperfusion injury of skeletal muscle. J Vasc Surg 1987, 6(3):231-234.
• [17]Eltzschig HK, Collard CD: Vascular ischaemia and reperfusion injury. British medical bulletin 2004, 70:71-86.
• [18]Elmali N, Esenkaya I, Karadag N, Tas F, Elmali N: Effects of resveratrol on skeletal muscle in ischemia-reperfusion injury. Ulus Travma Acil Cerrahi Derg 2007, 13(4):274-280.
• [19]Ozyurt H, Ozyurt B, Koca K, Ozgocmen S: Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress. Vascul Pharmacol 2007, 47(2–3):108-112.
• [20]Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N: Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev 2006, 12(1):9-20.
• [21]Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y: Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain research 2004, 1029(2):200-206.
• [22]Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T: Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 2005, 36(10):2220-2225.
• [23]Group EABIS: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003, 15(3):222-229.
• [24]Erkanli K, Kayalar N, Erkanli G, Ercan F, Sener G, Kirali K: Melatonin protects against ischemia/reperfusion injury in skeletal muscle. J Pineal Res 2005, 39(3):238-242.
• [25]McCormack MC, Kwon E, Eberlin KR, Randolph M, Friend DS, Thomas AC, Watkins MT, Austen WG Jr: Development of reproducible histologic injury severity scores: skeletal muscle reperfusion injury. Surgery 2008, 143(1):126-133.
• [26]Casini AF, Ferrali M, Pompella A, Maellaro E, Comporti M: Lipid peroxidation and cellular damage in extrahepatic tissues of bromobenzene-intoxicated mice. Am J Pathol 1986, 123(3):520-531.
• [27]Badcock NR, Zoanetti GD, Martin ES: Nonchromatographic assay for malondialdehyde-thiobarbituric acid adduct with HPLC equivalence. Clin Chem 1997, 43(9):1655-1657.
• [28]Yoshida H, Kwon AH, Kaibori M, Tsuji K, Habara K, Yamada M, Kamiyama Y, Nishizawa M, Ito S, Okumura T: Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes. Nitric oxide: biology and chemistry / official journal of the Nitric Oxide Society 2008, 18(2):105-112.
• [29]Filippin LI, Moreira AJ, Marroni NP, Xavier RM: Nitric oxide and repair of skeletal muscle injury. Nitric oxide: biology and chemistry / official journal of the Nitric Oxide Society 2009, 21(3–4):157-163.
• [30]Bujok G, Dyaczynska-Herman A, Jendryczko A, Mandat K, Sypniewski J: Concentration of malonic dialdehyde in the cerebrospinal fluid as a measure of the intensity of lipid peroxidation processes in intracranial hypertension in small children. Childs Nerv Syst 1996, 12(2):97-99.
• [31]Gute DC, Ishida T, Yarimizu K, Korthuis RJ: Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 1998, 179(1–2):169-187.
• [32]Mubarak SJ, Pedowitz RA, Hargens AR: Compartment syndromes. Curr Orthop 1989, 3:36-40.
• [33]Perry MO: Compartment syndromes and reperfusion injury. Surg Clin N Am 1988, 68(4):853-864.
• [34]Navein J, Coupland R, Dunn R: The tourniquet controversy. The Journal of trauma 2003, 54(5 Suppl):S219-S220.
• [35]Odeh M: The role of reperfusion-induced injury in the pathogenesis of the crush syndrome. N Engl J Med 1991, 324(20):1417-1422.
• [36]Malinoski DJ, Slater MS, Mullins RJ: Crush injury and rhabdomyolysis. Critical care clinics 2004, 20(1):171-192.
• [37]Kyriakides C, Favuzza J, Wang Y, Austen WG Jr, Moore FD Jr, Hechtman HB: Recombinant soluble P-selectin glycoprotein ligand 1 moderates local and remote injuries following experimental lower-torso ischaemia. Br J Surg 2001, 88(6):825-830.
• [38]Grace PA: Ischaemia-reperfusion injury. Br J Surg 1994, 81(5):637-647.
• [39]Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA: Melatonin reduces ischemia/reperfusion-induced superoxide generation in arterial wall and cell death in skeletal muscle. J Pineal Res 2006, 41(3):255-260.
• [40]Chen CJ, Cheng FC, Liao SL, Chen WY, Lin NN, Kuo JS: Effects of naloxone on lactate, pyruvate metabolism and antioxidant enzyme activity in rat cerebral ischemia/reperfusion. Neurosci Lett 2000, 287(2):113-116.
• [41]Omori K, Shikata Y, Sarai K, Watanabe N, Wada J, Goda N, Kataoka N, Shikata K, Makino H: Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells. Am J Physiol Cell Physiol 2007, 293(5):C1523-C1531.
• [42]Jugdutt BI: Nitric oxide and cardioprotection during ischemia-reperfusion. Hear Fail Rev 2002, 7(4):391-405.
• [43]Barker JE, Knight KR, Romeo R, Hurley JV, Morrison WA, Stewart AG: Targeted disruption of the nitric oxide synthase 2 gene protects against ischaemia/reperfusion injury to skeletal muscle. J Pathol 2001, 194(1):109-115.
• [44]Rubinstein I, Abassi Z, Coleman R, Milman F, Winaver J, Better OS: Involvement of nitric oxide system in experimental muscle crush injury. J Clin Invest 1998, 101(6):1325-1333.
• [45]Anggard E: Nitric oxide: mediator, murderer, and medicine. Lancet 1994, 343(8907):1199-1206.